Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label study of inhaled human insulin powder versus injectable prandial insulin in type 1 diabetes
2005-000566-40Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of insulin human in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Change in HbA1c from baseline to endpoint and Safety assessment. Started Nov 2005; status: completed.
02
Drugs
insulin human
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2005-000566-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000566-40.